We are live on ! Find out more
VFA

Virtus Fund Advisers Portfolio holdings

AUM $32.1M
1-Year Est. Return 39.5%
This Fund
S&P 500
This Quarter Est. Return
+9.15%
1 Year Est. Return
+39.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25.3M
AUM Growth
-$3.03M
Cap. Flow
-$4.59M
Cap. Flow %
-18.16%
Top 10 Hldgs %
77.23%
Holding
137
New
23
Increased
71
Reduced
13
Closed
24

Top Buys

Rank Stock Value
1
MMYT icon
MakeMyTrip
MMYT
+$1.68M
2
TK icon
Teekay
TK
+$493K
3
IBN icon
ICICI Bank
IBN
+$492K
4
NCLH icon
Norwegian Cruise Line
NCLH
+$107K
5
PRIM icon
Primoris Services
PRIM
+$86.8K

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$1.7M
2
HCC icon
Warrior Met Coal
HCC
+$1.55M
3
AAPL icon
Apple
AAPL
+$1.25M
4
MSFT icon
Microsoft
MSFT
+$1.07M
5
CMPR icon
Cimpress
CMPR
+$524K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.16%
2 Energy 18.01%
3 Financials 13.56%
4 Healthcare 5.85%
5 Materials 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KNF icon
26
Knife River
KNF
$4.32B
$87.5K 0.35%
1,248
+34
+3% +$2.54K
PRIM icon
27
Primoris Services
PRIM
$4.17B
$87.5K 0.35%
+1,754
New +$86.8K
MMSI icon
28
Merit Medical Systems
MMSI
$4.76B
$87.5K 0.35%
1,018
+48
+5% +$3.77K
MTG icon
29
MGIC Investment
MTG
$6.52B
$87.2K 0.35%
4,045
+195
+5% +$4.04K
STRA icon
30
Strategic Education
STRA
$1.98B
$86K 0.34%
777
+77
+11% +$8.52K
TWST icon
31
Twist Bioscience
TWST
$5.32B
$85.5K 0.34%
1,736
+107
+7% +$4.36K
KBH icon
32
KB Home
KBH
$3.5B
$84.9K 0.34%
1,210
+35
+3% +$2.38K
EXP icon
33
Eagle Materials
EXP
$6.56B
$83.7K 0.33%
385
+25
+7% +$6.12K
VCYT icon
34
Veracyte
VCYT
$4.43B
$78.2K 0.31%
3,609
+138
+4% +$2.9K
ACLS icon
35
Axcelis
ACLS
$3.5B
$78.2K 0.31%
550
+34
+7% +$3.92K
FN icon
36
Fabrinet
FN
$14.7B
$77.8K 0.31%
318
+17
+6% +$3.61K
NTRA icon
37
Natera
NTRA
$35.9B
$74.4K 0.29%
687
+71
+12% +$7.21K
KEX icon
38
Kirby Corp
KEX
$7.12B
$71.8K 0.28%
+600
New +$67K
PRGO icon
39
Perrigo
PRGO
$1.42B
$70.3K 0.28%
+2,737
New +$80.4K
ANIK icon
40
Anika Therapeutics
ANIK
$222M
$66.6K 0.26%
2,630
+71
+3% +$1.84K
TTEK icon
41
Tetra Tech
TTEK
$8.93B
$65.4K 0.26%
1,600
-530
-25% -$21.6K
ESNT icon
42
Essent Group
ESNT
$6.3B
$65.3K 0.26%
1,162
+70
+6% +$3.9K
AMWD
43
DELISTED
American Woodmark
AMWD
$64.8K 0.26%
824
+51
+7% +$4.6K
BL icon
44
BlackLine
BL
$1.92B
$64.1K 0.25%
1,324
-522
-28% -$28.7K
UCTT
45
Ultra Clean Holdings
UCTT
$3.18B
$63.7K 0.25%
+1,299
New +$58.3K
ANIP icon
46
ANI Pharmaceuticals
ANIP
$1.85B
$62.9K 0.25%
987
+117
+13% +$7.6K
TAC icon
47
TransAlta
TAC
$3.94B
$61.4K 0.24%
8,676
+5,679
+189% +$38.9K
GFF icon
48
Griffon
GFF
$4.03B
$60.6K 0.24%
+949
New +$64.2K
R icon
49
Ryder
R
$9.84B
$58.2K 0.23%
470
+61
+15% +$7.37K
UFPI icon
50
UFP Industries
UFPI
$5B
$58K 0.23%
518
+7
+1% +$814

Similar funds

Virtus Fund Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Virtus Fund Advisers held 137 positions worth $25.3M, down 11% from $28.3M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Virtus Fund Advisers withdrew a net $4.59M in Q2 2024, closing 24 positions and reducing 13 holdings. Its most notable exit was Dr. Reddy's Laboratories, an estimated $1.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

Against the trend, Virtus Fund Advisers opened a new position in Norwegian Cruise Line worth $115K.

  • Virtus Fund Advisers's largest Q2 2024 buy was Norwegian Cruise Line: 6,114 shares worth $115K.
  • Virtus Fund Advisers added most to MakeMyTrip in Q2 2024, an estimated $1.68M increase.
  • Virtus Fund Advisers's biggest Q2 2024 reduction was Warrior Met Coal, cutting an estimated $1.55M.
  • Virtus Fund Advisers fully exited Dr. Reddy's Laboratories in Q2 2024, selling an estimated $1.7M.
  • Virtus Fund Advisers's ten largest holdings make up 77% of its $25.3M portfolio in Q2 2024.
  • Virtus Fund Advisers opened 23 new positions and closed 24 in Q2 2024.
  • Virtus Fund Advisers's portfolio value fell 11% quarter-over-quarter to $25.3M.

Based on Virtus Fund Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.